Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents

References

• Lang F, Artunc F, Vallon V. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1. Curr Opin Nephrol Hypertens. 2009;18(5):439–448.
   PubMed Web of Science ®Google Scholar
• Lang F, Stournaras C, Zacharopoulou N, Voelkl J, Alesutan I. Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress. Cell Stress. 2018;3(1):1–8.
   PubMedGoogle Scholar
• Engelsberg A, Kobelt F, Kuhl D. The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover. Biochem J. 2006;399(1):69–76.
   PubMedGoogle Scholar
• Zhao B, Lehr R, Smallwood AM, Ho TF, Maley K, Randall T, Head MS, Koretke KK, Schnackenberg CG. Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP. Protein Sci. 2007;16(12):2761–2769.
   PubMed Web of Science ®Google Scholar
• Hammond M, Washburn DG, Hoang HT, Manns S, Frazee JS, Nakamura H, Patterson JR, Trizna W, Wu C, Azzarano LM, et al. Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1(SGK1) inhibitors. Bioorg Med Chem Lett. 2009;19(15):4441–4445.
   PubMed Web of Science ®Google Scholar
• Cheng HC, Qi RZ, Paudel H, Zhu HJ. Regulation and function of protein kinases and phosphatases. Enzyme Res. 2011;2011:794089.
   PubMedGoogle Scholar
• Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 2009;9(1):28–39.
   PubMed Web of Science ®Google Scholar
• Roskoski R. Jr., Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update. Pharmacol Res. 2022;175:106037.
   PubMed Web of Science ®Google Scholar
• Maestro I, Boya P, Martinez A. Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases. Expert Opin Ther Targets. 2020;24(3):231–243.
   PubMed Web of Science ®Google Scholar
• Schoenebeck B, Bader V, Zhu XR, Schmitz B, Lubbert H, Stichel CC. Sgk1, a cell survival response in neurodegenerative diseases. Mol Cell Neurosci. 2005;30(2):249–264.
   PubMed Web of Science ®Google Scholar
• Iwata S, Nomoto M, Morioka H, Miyata A. Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice. Synapse. 2004;51(4):279–286.
   PubMed Web of Science ®Google Scholar
• Elahi M, Motoi Y, Shimonaka S, Ishida Y, Hioki H, Takanashi M, Ishiguro K, Imai Y, Hattori N. High-fat diet-induced activation of SGK1 promotes Alzheimer’s disease-associated tau pathology. Hum Mol Genet. 2021;30(18):1693–1710.
   PubMed Web of Science ®Google Scholar
• Virdee K, Yoshida H, Peak-Chew S, Goedert M. Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. FEBS Lett. 2007;581(14):2657–2662.
   PubMed Web of Science ®Google Scholar
• Duka V, Lee JH, Credle J, Wills J, Oaks A, Smolinsky C, Shah K, Mash DC, Masliah E, Sidhu A. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer’s diseases. PLoS One. 2013;8(9):e75025.
   PubMed Web of Science ®Google Scholar
• Sherk AB, Frigo DE, Schnackenberg CG, Bray JD, Laping NJ, Trizna W, Hammond M, Patterson JR, Thompson SK, Kazmin D, et al. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. Cancer Res. 2008;68(18):7475–7483.
   PubMed Web of Science ®Google Scholar
• Ackermann TF, Boini KM, Beier N, Scholz W, Fuchss T, Lang F. EMD638683, a novel SGK inhibitor with antihypertensive potency. Cell Physiol Biochem. 2011;28(1):137–146.
   PubMedGoogle Scholar
• Ortuso F, Amato R, Artese A, D'Antona L, Costa G, Talarico C, Gigliotti F, Bianco C, Trapasso F, Schenone S, et al. In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold. J Chem Inf Model. 2014;54(7):1828–1832.
   PubMed Web of Science ®Google Scholar
• Mehrpour M, Esclatine A, Beau I, Codogno P. Overview of macroautophagy regulation in mammalian cells. Cell Res. 2010;20(7):748–762.
   PubMed Web of Science ®Google Scholar
• Ballesteros-Alvarez J, Andersen JK. mTORC2: The other mTOR in autophagy regulation. Aging Cell. 2021;20(8):e13431.
   PubMed Web of Science ®Google Scholar
• Lu M, Wang J, Jones KT, Ives HE, Feldman ME, Yao LJ, Shokat KM, Ashrafi K, Pearce D. mTOR complex-2 activates ENaC by phosphorylating SGK1. J Am Soc Nephrol. 2010;21(5):811–818.
   PubMed Web of Science ®Google Scholar
• Zuleger T, Heinzelbecker J, Takacs Z, Hunter C, Voelkl J, Lang F, Proikas-Cezanne T. SGK1 Inhibits Autophagy in Murine Muscle Tissue. Oxid Med Cell Longev. 2018;2018:4043726.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X, Liu Z, Wang Y, Yin B, Yu P, Duan X, Liao Z, Chen Y, Liu C, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway. Br J Cancer. 2017;117(8):1139–1153.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X, Wang Y, Dai Y, Xie Y, Ping Y, Yin B, Yu P, Liu Z, Duan X, et al. SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT. J Exp Clin Cancer Res. 2018;37(1):73.
   PubMedGoogle Scholar
• Tang X, Sun Y, Xu C, Guo X, Sun J, Pan C, Sun J. Caffeine Induces Autophagy and Apoptosis in Auditory Hair Cells via the SGK1/HIF-1alpha Pathway. Front Cell Dev Biol. 2021;9:751012.
   PubMed Web of Science ®Google Scholar
• Maestro I, de la Ballina LR, Simonsen A, Boya P, Martinez A. Phenotypic Assay Leads to Discovery of Mitophagy Inducers with Therapeutic Potential for PRKNson’s Disease. ACS Chem Neurosci. 2021;12(24):4512–4523.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu N, Lu B. Mechanisms and roles of mitophagy in neurodegenerative diseases. CNS Neurosci Ther. 2019;25(7):859–875.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.
   PubMed Web of Science ®Google Scholar
• Daina A, Zoete V. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem. 2016;11(11):1117–1121.
   PubMed Web of Science ®Google Scholar
• Protein Preparation Wizard;Epik, Schrödinger, LLC, New York, NY, 2021; Impact, Schrödinger, LLC, New York, NY; Prime, Schrödinger, LLC, New York, NY, 2021.
   Google Scholar
• LigPrep, Schrödinger, LLC, New York, NY, 2021.
   Google Scholar
• Glide S. Glide, Schrödinger. LLC, New York, NY. 2017.
   Google Scholar
• Sebastian-Perez V, Roca C, Awale M, Reymond JL, Martinez A, Gil C, Campillo NE. Medicinal and Biological Chemistry(MBC) Library: An Efficient Source of New Hits. J Chem Inf Model. 2017;57(9):2143–2151.
   PubMed Web of Science ®Google Scholar
• Princely Abudu Y, Pankiv S, Mathai BJ, Hakon Lystad A, Bindesboll C, Brenne HB, Yoke Wui Ng M, Thiede B, Yamamoto A, Mutugi Nthiga T, et al. NIPSNAP1 and NIPSNAP2 Act as “Eat Me” Signals for Mitophagy. Dev Cell. 2019;49(4):509–525 e12.
   PubMed Web of Science ®Google Scholar
• Allen GF, Toth R, James J, Ganley IG. Loss of iron triggers PINK1/PRKN-independent mitophagy. EMBO Rep. 2013;14(12):1127–1135.
   PubMed Web of Science ®Google Scholar
• Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7(10):R100.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem. 2003;38(3):223–232.
   PubMed Web of Science ®Google Scholar
• Pantsar T, Poso A. Binding Affinity via Docking: Fact and Fiction. Molecules. 2018;23(8):1899.
   PubMed Web of Science ®Google Scholar
• Tang MY, Vranas M, Krahn AI, Pundlik S, Trempe JF, Fon EA. Structure-guided mutagenesis reveals a hierarchical mechanism of PRKN activation. Nat Commun. 2017;8:14697.
   PubMed Web of Science ®Google Scholar
• Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991;266(26):17707–17712.
   PubMed Web of Science ®Google Scholar
• Kamat PK, Rai S, Nath C. Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer’s disease pathology. Neurotoxicology. 2013;37:163–172.
   PubMed Web of Science ®Google Scholar